We have developed improved procedures for the isolation of deletion mutant, point mutant, and recombinant herpesvirus saimiri. 
Large DNA viruses, such as the orthopoxviruses and herpesviruses, are useful as gene transfer vectors, because they can easily accommodate substantial amounts of additional DNA in their genomes (1) (2) (3) . Accessory genes unnecessary for replication of these viruses can be eliminated to modulate the virus' properties and to help ensure their safety. In the case of herpesviruses, persistence of the viral genetic information may be useful for some applications where continued foreign gene expression is desirable. We have been manipulating the genetic information of herpesvirus saimiri (HVS) to obtain a better understanding of its natural life cycle and to use it as a gene transfer vector for experimental vaccine and therapeutic strategies.
HVS infection is endemic and apparently apathogenic in squirrel monkeys (Saimiri sciureus; refs. [4] [5] [6] . The virus is extremely oncogenic, however, in other nonhuman primates, producing fulminant T-cell lymphoproliferative diseases (7, 8) . HVS is the prototypic and best characterized y-2 herpesvirus (Rhadinovirus; refs. 9 and 10). The only known human y-2 herpesvirus, the recently discovered human herpesvirus 8, or Kaposi sarcoma associated herpesvirus, shows greatest homology with HVS and shares a similar genomic organization (11, 12) . Studies on the mechanisms of HVS oncogenicity are expected to contribute to the understanding of Kaposi sarcoma and possibly other disorders believed to be associated with human herpesvirus 8 infection (13) (14) (15) .
Previous characterization of HVS oncogenesis has demonstrated that sequences near the left end of the viral genome are unnecessary for viral replication but essential for oncogenesis and in vitro transformation of common marmoset lymphocytes (16) (17) (18) (19) . This region contains an oncogene designated as saimiri transforming protein (STP; refs. 20 and 21) . The complete nucleotide sequence of HVS subgroup A strain 11 has revealed other open reading frames that possibly contribute to the transforming capacity of the virus (22) . Among these are genes encoding a viral cyclin related to cyclin Dl (23, 24) , a homolog of the superantigen of mouse mammary tumor virus (25) , a CD-59 homolog (26), a G protein-coupled receptor homologous to the cellular interleukin 8 receptor (27) , a Bcl-2 homolog (28), and an interleukin 17 homolog (29, 30) . Striking sequence differences have been noted between viruses in subgroup A and the more oncogenic subgroup C in the region of the genome containing the STP oncogene (20, 21) . Highly oncogenic subgroup C isolates of HVS immortalize human and rhesus monkey T lymphocytes in vitro (31, 32) , and they contain a divergent STP gene (20, 21) and a unique gene encoding tyrosine kinase interacting protein (Tip), which interacts with the major T-cell tyrosine kinase Lck (33) (34) (35) 40 (SV40) early promoter and enhancer. Polymerase chain reaction (PCR) using Vent polymerase (New England Biolabs) was employed to amplify components of the expression cassettes from commercially available plasmids and to add selected restriction enzyme sites. SV40 early promoter, enhancer, and polyadenylylation elements with a NotI site available for insertion of a reporter gene were amplified from a modified pSVf3 (CLONTECH) from which the LacZ reporter had been eliminated by NotI digestion and ligation to produce a reporterless vector. The 5' primer, CGCGGTACCGATATCGCCG-GCGCGCCGGTACAGCTTGTGGAATGTGTGTCA, added KpnI, EcoRV, SgrAI, andAscl restriction sites while the 3' primer, CGCTCTAGAGCTCACGTGGCGCGCCG-GCGGATAAAAACCTCCCACACCT, added XbaI, Sacd, PmlI,AscI, and SgrAI sites. Digestion of the PCR product with KpnI and XbaI allowed cloning of the control elements into corresponding sites in pNEB193 (New England Biolabs).
The SEAP reporter was amplified from pBC12/PL/SEAP (Tropix, Bedford, MA) using primers that added flanking NotI sites. Primers used were AGAGAATTCGCGGCCG-CATATCGTCGACAAGCTTCTGC and CAGTCTA-GAGCGGCCGCGGGTTAACCCGGGTGCGCGGCG.
NotI-digested PCR product was cloned into the NotI site of the vector containing SV40 control elements to produce the plasmid pSV40/SEAP. The similar GFP expression cassette was constructed by deleting the SEAP gene from the expression cassette with Sall and SmaI and inserting GFP from pGFP (CLONTECH) digested with Sall and StuI.
Reporter function was tested by DEAE-dextran-mediated transfection into COS-1 cells (38), followed by assay of expression at 48-72 hr posttransfection. SEAP production and secretion was detected by liquid scintillation counter measurement of chemiluminescence produced in assays of cell culture medium using Phospha-Light reagents (Tropix, Bedford, MA) according to the manufacturer's recommendations. GFP production was detected visually by observation of bright green fluorescence produced at an excitation wavelength of 495 nm using an Olympus IMT-2 fluorescence microscope.
Gene Deletion Plasmid Construction. A 3.6-kb plasmid clone (p488PX) of a PstI/XbaI fragment derived from the left end of the herpesvirus saimiri group C strain 488 genome and containing the STP-C488 oncogene has been described (21 
RESULTS
Isolation of a HVS Recombinant Using a SEAP Reporter as a Selection Marker. An SV40 early promoter-driven SEAP expression cassette was designed for insertion into cloned HVS genes considered likely to be nonessential for virus replication. One such gene, the STP-C488 oncogene, was targeted for deletion by inserting the SV40/SEAP reporter in place of a 508-bp SpeI/EcoRV fragment (including most of the STP gene) in a 3.6-kb plasmid clone. The selection method for the recombinant virus is illustrated in Fig. 1 uniformly SEAP-negative virus (see Fig. 1 for schematic) . The success of this manipulation suggested that the AscI and NotI restriction sites may also be useful for direct cloning approaches for construction of HVS gene transfer vectors.
Replacement of the SV40/SEAP Expression Cassette in Recombinant HVS Using Homologous Recombination or Direct Cloning Strategies. Fig. 2 illustrates alternative strategies for the use of nononcogenic HVS deletion mutant viruses containing SV40/SEAP for construction of gene transfer vectors. Homologous recombination can clearly be used to replace the SEAP expression cassette with another expression cassette essentially by the same procedure used for selection of the STP-C488-deleted recombinant virus (Fig. 1) . In this case, however, loss of SEAP expression serves as the selection marker. To demonstrate the general applicability of this procedure for gene replacement, we employed an additional deletion mutant virus, HVSATip/SV40-SEAP. Replacement of the SV40/SEAP reporter in the HVSATip/ SV40-SEAP virus with the comparable SV40/GFP cassette by homologous recombination was performed as outlined in Fig.  2A . Approximately 2% of the wells plated in the first limiting dilution passage after the mixed transfection showed strong green fluorescence. Also, this homologous recombination method was similarly used to restore the wild-type STP-C488 gene to the STP-deleted recombinant virus (marker rescue).
Insertion of a foreign gene (GFP) into the HVSASTP/ SV40-SEAP virus was achieved by direct cloning into the AscI sites of virion DNA as described in Materials and Methods and illustrated in Fig. 2B . An SV40/GFP expression cassette was directly inserted as an AscI fragment into virion DNA and transfected into OMK cells. Virus produced by transfection of the ligation mixture was diluted and plated in multiwell plates such that there was less than one infectious particle per well. SEAP and GFP expression was assessed for each infected well (Table 1) . SEAP activity was completely eliminated by AscI digestion. From a total of 40 virus infected wells that we observed, cells from 36 wells fluoresced brightly green ( Fig. 3 and Table 1 have been previously reported (39) (40) (41) . Application of each of these selection markers to the process of identifying recombinant HVS is a significant advance compared with methods previously used to isolate deletion mutants of HVS or other herpesviruses (1, 18, 19) . Assay for SEAP requires only a minute sample of culture medium for a rapid and sensitive test. Assay of cell-free supernatant for SEAP may also be useful for detecting recombinant viruses with minimal lytic activity. Use of GFP requires no sampling and no additional reagents. The level of GFP expression was sufficient in the HVS recombinants to produce a fluorescent signal that was readily detected microscopically. While the wild-type Aequorea GFP used was more than adequate in intensity to detect fluorescence, variants are now available that are brighter, have different excitation and/or emission spectra, and are optimized in codon usage for maximum expression in mammalian cells (42) (43) (44) (45) . Both SEAP and GFP provide the opportunity for reduction of the time required for recombinant virus identification and isolation. Early detection of recombinants is possible before extensive cytopathic effect is observed and does not disturb the continued growth of the virus to high titers.
Positive selection of SEAP or GFP aids in isolation of initial recombinant HVS and then provides in the purified recombinant the equally useful negative selection tool, loss of the reporter, for isolation of marker-rescued virus or other recombinants as desired. We are currently using these procedures to isolate HVS strains with point mutations in STP and Tip and to isolate HVS recombinants capable of expressing antigens of other organisms for the purpose of vaccination.
Inclusion of unique restriction sites flanking the reporter gene in recombinant HVS greatly facilitates subsequent genetic manipulation and allows use of virion DNA directly as a cloning vector. Similar direct cloning into a large DNA virus, a baculovirus, has been reported (46) . Simple removal of the reporter gene may be desirable for some in vivo applications. The NotI and AscI sites were intentionally positioned to allow removal of the reporter gene open reading frame alone, or in combination with the promoter and poly(A) elements. Any gene with or without a promoter can in theory be cloned directly into the virion DNA when flanked by the appropriate NotI orAscl sites. To our knowledge, this is the first report of direct cloning into a herpesvirus. The procedures outlined here are expected to be particularly flexible for a variety of applications.
